Robert Woolson to Fibrinolytic Agents
This is a "connection" page, showing publications Robert Woolson has written about Fibrinolytic Agents.
Connection Strength
0.267
-
Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Stroke. 1994 Sep; 25(9):1746-51.
Score: 0.090
-
Use of antithrombotic drugs in the treatment of acute ischemic stroke: a survey of neurologists in practice in the United States. Neurology. 1989 Dec; 39(12):1631-4.
Score: 0.065
-
Antithrombotic treatment of ischemic stroke among patients with occlusion or severe stenosis of the internal carotid artery: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology. 1999 Jul 13; 53(1):122-5.
Score: 0.032
-
Design of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Control Clin Trials. 1997 Aug; 18(4):358-77.
Score: 0.028
-
Challenges of decision making regarding futility in a randomized trial: the Interventional Management of Stroke III experience. Stroke. 2014 May; 45(5):1408-14.
Score: 0.022
-
Studies of Org 10172 in patients with acute ischemic stroke. TOAST Study Group. Haemostasis. 1992; 22(2):99-103.
Score: 0.019
-
Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1994 Sep; 25(9):1901-14.
Score: 0.006
-
Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation. 1994 Sep; 90(3):1588-601.
Score: 0.006